Detailed information for compound 716002

Basic information

Technical information
  • TDR Targets ID: 716002
  • Name: N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-(5-methyl furan-2-yl)propanamide
  • MW: 265.331 | Formula: C12H15N3O2S
  • H donors: 1 H acceptors: 3 LogP: 2.1 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCc1nnc(s1)NC(=O)CCc1ccc(o1)C
  • InChi: 1S/C12H15N3O2S/c1-3-11-14-15-12(18-11)13-10(16)7-6-9-5-4-8(2)17-9/h4-5H,3,6-7H2,1-2H3,(H,13,15,16)
  • InChiKey: KCOBRWKUEOSGAB-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-(5-methyl-2-furyl)propanamide
  • N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-(5-methyl-2-furyl)propionamide
  • ZINC02708061
  • MLS000538610
  • SMR000144647

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Homo sapiens GNAS complex locus Starlite/ChEMBL No references
Mus musculus RAR-related orphan receptor gamma Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma japonicum ko:K04632 guanine nucleotide binding protein (G protein), alpha stimulating, putative Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni GTP-binding protein alpha subunit gna GNAS complex locus 394 aa 450 aa 28.7 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.003 0.4237 0.4237
Brugia malayi AMP-binding enzyme family protein 0.0023 0.2496 0.2496
Brugia malayi hypothetical protein 0.003 0.4237 0.4237
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0035 0.5256 0.5256
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0023 0.2496 1
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.4237 0.5
Chlamydia trachomatis acylglycerophosphoethanolamine acyltransferase 0.0017 0.1148 0.5
Loa Loa (eye worm) hypothetical protein 0.0017 0.1148 0.1148
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.4237 1
Onchocerca volvulus 0.0023 0.2496 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 1 1
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.2496 1
Entamoeba histolytica hypothetical protein 0.0035 0.5256 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 1 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 1 1
Entamoeba histolytica hypothetical protein 0.0035 0.5256 1
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.4237 1
Schistosoma mansoni transcription factor LCR-F1 0.0035 0.5256 0.5256
Plasmodium vivax ataxin-2 like protein, putative 0.003 0.4237 1
Loa Loa (eye worm) hypothetical protein 0.0023 0.2496 0.2496
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 1 1
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.4237 0.5
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.2496 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0023 0.2496 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 1 1
Mycobacterium tuberculosis Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) 0.0017 0.1148 0.139
Loa Loa (eye worm) hypothetical protein 0.0023 0.2496 0.2496
Schistosoma mansoni hypothetical protein 0.0035 0.5256 0.5256
Loa Loa (eye worm) hypothetical protein 0.0017 0.1148 0.1148
Entamoeba histolytica hypothetical protein 0.0035 0.5256 1
Brugia malayi hypothetical protein 0.002 0.173 0.173
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.2496 1
Brugia malayi AMP-binding enzyme family protein 0.0023 0.2496 0.2496
Brugia malayi AMP-binding enzyme family protein 0.0023 0.2496 0.2496
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0023 0.2496 0.5
Brugia malayi hypothetical protein 0.0035 0.5256 0.5256
Loa Loa (eye worm) hypothetical protein 0.0023 0.2496 0.2496
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0023 0.2496 0.5
Toxoplasma gondii LsmAD domain-containing protein 0.003 0.4237 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 1 1
Loa Loa (eye worm) hypothetical protein 0.0017 0.1148 0.1148
Mycobacterium ulcerans hypothetical protein 0.0023 0.2496 1
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0023 0.2496 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0055 1 1
Loa Loa (eye worm) hypothetical protein 0.0017 0.1148 0.1148
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 1 1
Leishmania major hypothetical protein, conserved 0.003 0.4237 1
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0023 0.2496 1
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0014 0.0336 0.0336
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0023 0.2496 1
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.4237 0.5
Entamoeba histolytica hypothetical protein 0.0035 0.5256 1
Loa Loa (eye worm) hypothetical protein 0.0017 0.1148 0.1148
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0014 0.0336 0.0336
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0035 0.5256 0.5256
Schistosoma mansoni hypothetical protein 0.0014 0.0336 0.0336
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0023 0.2496 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 1 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 12.5893 um PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 12.5893 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.